Cargando…

Long-term outcomes in health-related quality of life influence chronic disease management in patients with pulmonary hypertension

BACKGROUND: Significantly improved survival in patients with pulmonary hypertension (PH) has raised interest in maintaining a good quality of long-term survivorship. In this study, health-related quality of life (HRQOL) measurement was used to assess the long-term changes of physical and mental outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jin-Ling, Xiao, Fan, Liu, Hong-Ting, Li, Hui-Ting, Zhao, Qin-Hua, Sun, Chun-Yan, Zhu, Yan, Yan, Lei, Wang, Wen-Yue, Luo, Hui, Gong, Su-Gang, Jiang, Rong, Liu, Jin-Ming, Zhang, Rui, Wang, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685316/ https://www.ncbi.nlm.nih.gov/pubmed/36440006 http://dx.doi.org/10.3389/fcvm.2022.1008253

Ejemplares similares

Sex-specific differences in sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease
por: Li, Hui-Ting, et al.
Publicado: (2022)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Li, Jie, et al.
Publicado: (2022)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Comparative Effectiveness of Exercise Training for Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy: A Systematic Review and Meta-Analysis
por: Zhao, Ya-Lin, et al.
Publicado: (2021)

Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
por: Lu, Gang-Hua, et al.
Publicado: (2020)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
por: Wang, Rui, et al.
Publicado: (2022)

Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension
por: Zhang, Yi, et al.
Publicado: (2021)

Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Li, Xin, et al.
Publicado: (2021)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China
por: Luo, Cijun, et al.
Publicado: (2021)

Case report: Thoughts on two cases of total anomalous pulmonary venous connection complicated with pulmonary artery hypertension
por: Yan, Ling, et al.
Publicado: (2023)

Associations of Renalase With Blood Pressure and Hypertension in Chinese Adults
por: Wang, Yang, et al.
Publicado: (2022)

Heart-Rate Recovery at 1 Min After Exercise Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Zhang, Yi, et al.
Publicado: (2022)

Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production
por: Shu, Ting, et al.
Publicado: (2021)

Right Ventricular Diastolic Performance in Patients With Chronic Thromboembolic Pulmonary Hypertension Assessed by Echocardiography
por: Meng, Hong, et al.
Publicado: (2021)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
por: Yang, Lei, et al.
Publicado: (2023)

Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

The Association of Morning Hypertension With Target Organ Damage in Patients With Chronic Kidney Disease and Hypertension
por: Liu, Xiang, et al.
Publicado: (2021)

Predictors of Maternal Death Among Women With Pulmonary Hypertension in China From 2012 to 2020: A Retrospective Single-Center Study
por: Dai, Ling-Ling, et al.
Publicado: (2022)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure
por: Xu, Yu, et al.
Publicado: (2023)

Effect of Exercise Prescription Implementation Rate on Cardiovascular Events
por: Zhu, Li-Yue, et al.
Publicado: (2022)

Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study
por: Zheng, Yan, et al.
Publicado: (2022)

Selexipag-based triple combination therapy improves prognosis in Chinese pulmonary arterial hypertension patients
por: Cui, Xiaopei, et al.
Publicado: (2022)

Case report: pulmonary artery perforation during transseptal puncture for left atrial appendage closure requires emergency cardiac operation
por: Wang, Yue, et al.
Publicado: (2023)

Similarities in Hypertension Status but Differences in Mortality Risk: A Comparison of 2017 ACC/AHA and 2018 Chinese Hypertension Guidelines
por: Chen, Kangyu, et al.
Publicado: (2022)

Clinical observation of sacubitril valsartan sodium in the treatment of resistant hypertension: A randomized clinical trial
por: Lyu, Tian-Jiao, et al.
Publicado: (2022)

Effects of Intermittent Compared With Continuous Energy Restriction on Blood Pressure Control in Overweight and Obese Patients With Hypertension
por: He, Chao-Jie, et al.
Publicado: (2021)

White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Wu, Ting-Ting, et al.
Publicado: (2021)

Associations of Serum Uromodulin and Its Genetic Variants With Blood Pressure and Hypertension in Chinese Adults
por: Wang, Yang, et al.
Publicado: (2021)

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients
por: Lan, Wei-Fang, et al.
Publicado: (2022)

Correlation between serum GDF-15 level and pulmonary vascular morphological changes and prognosis in patients with pulmonary arterial hypertension
por: Maimaiti, Yasenjiang, et al.
Publicado: (2023)

Editorial: Advances in understanding the mechanisms of pulmonary hypertension
por: Ahmad, Ashfaq, et al.
Publicado: (2023)

An unexpected cause of pulmonary hypertension
por: Cao, Yunshan, et al.
Publicado: (2020)

Pre-operative evaluation and mid-term outcomes of anomalous origin of the left coronary artery from the pulmonary artery based on left ventricular ejection fraction
por: Xia, Shu-Liang, et al.
Publicado: (2022)

A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial
por: Jiang, Rong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17qrh0qjvhq2t5taruunegpof4